Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chondroitin sulfate E (CS-E) is a highly sulfated glycosaminoglycan characterized by a repeating disaccharide unit of D-glucuronic acid and N-acetyl-D-galactosamine, with sulfation at both the C4 and C6 positions of the galactosamine residue. It is a key component of the extracellular matrix and cell surface proteoglycans, playing critical roles in cell adhesion, migration, angiogenesis, and signal transduction. CS-E acts as a functional ligand or co-receptor for various growth factors, chemokines, and cell surface receptors, such as midkine, pleiotrophin, VEGF, and contactin-1. In disease states, CS-E is upregulated in several cancers (including prostate, breast, and ovarian cancers), where it promotes tumor progression, metastasis, and therapeutic resistance by activating oncogenic pathways like IL-6/STAT3 and Wnt/beta-catenin. It is also implicated in inflammatory conditions like osteoarthritis and rheumatoid arthritis, as well as the inhibition of neural repair following central nervous system injury. Therapeutic strategies targeting CS-E include small-molecule inhibitors of its biosynthetic enzyme CHST15 (such as Chst15-IN-1), enzymatic degradation using chondroitinase ABC, and specific monoclonal antibodies (such as GD3G7, E-12C, and E-18H) to neutralize its activity or serve as diagnostic biomarkers.
Inhibition of CHST15 (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) to reduce CS-E biosynthesis, enzymatic degradation of chondroitin sulfate chains, or monoclonal antibody binding and neutralization of CS-E.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chondroitin sulfate E (CS-E).